Menopausal hormone therapy tends to attract two kinds of certainty online: it is either presented as the answer to nearly every midlife problem or as something no sensible person should consider. Neither framing is especially useful.
Hormone therapy is not a single product, and the decision is not a referendum on whether hormones are “good” or “bad.” The useful conversation is more specific: What symptom are you trying to treat? What type of therapy is being considered? What does your personal health history change? What alternatives are available? How will benefit and risk be reviewed over time?
Start with the symptom, not the identity
Systemic estrogen is the most effective treatment for hot flashes and night sweats, according to ACOG, and it can also help protect against bone loss early in menopause. Local vaginal estrogen does a different job: it addresses vaginal dryness and related genitourinary symptoms with much lower systemic exposure.
Those are two separate decisions, and they get collapsed into one constantly. A woman whose real complaint is painful sex does not automatically need the treatment aimed at vasomotor symptoms, and a woman soaked at three in the morning by night sweats is not going to be rescued by a vaginal preparation. Menopause having arrived is not, by itself, a reason to treat anything. A symptom that is costing you something is.
The one fact that changes the prescription
If you still have a uterus, systemic estrogen is generally paired with a progestogen. That is not a formality. Unopposed estrogen raises the risk of endometrial cancer, and the progestogen is there to reduce it. Dose, route, and schedule are all an individualized discussion. Whether the second hormone belongs in the plan at all is not really a discussion. It follows from your anatomy.
I mention it plainly because it is the detail that goes missing when hormones are bought online, or when a clinic hands over a cream without ever asking whether you have had a hysterectomy. A prescriber who does not ask that question has told you something about the care you are about to receive.
Health history changes the risk conversation
Systemic hormone therapy is usually not recommended, ACOG notes, for people with certain histories, including some hormone-sensitive cancers, stroke, heart attack, blood clots, or liver disease. That is a compressed summary of the guidance, not the whole of it, and it is the sort of list that should be read against your own chart rather than skimmed on a phone. Age, time since menopause, migraine history, cardiovascular risk, and the route the estrogen takes can each move the calculation.
Which is why “everyone should be on HRT” is not evidence-aware care, and neither is “no one should.” Both sentences were written by someone who has never seen your history. The person who has seen it is the one worth talking to.
Compounded does not automatically mean safer or more personal
“Bioidentical” is doing marketing work more often than chemical work. Some FDA-approved menopausal hormone therapies already use hormones that are chemically identical to hormones made by the body, which means the word alone tells you very little about what is in the bottle. ACOG generally recommends FDA-approved products over custom-compounded hormone therapy when approved options can meet the need, because approved products come with standardized manufacturing and safety information.
A customized label should not substitute for a clear reason to use a compounded product. If a compounded formulation is genuinely the right answer for you, a clinician can say why in one sentence. Ask for the sentence.
Hormone therapy is not a weight-loss treatment
This one comes up almost every time, usually late in the appointment and slightly apologetically. Menopausal hormone therapy by itself does not cause weight loss; that is ACOG’s current patient guidance, stated directly. It may change fat distribution, and treating disruptive night sweats may indirectly help sleep, which matters for overall health. Helping you sleep through the night is a real benefit. It is not the same thing as a weight-loss intervention, and a prescriber who blurs the two is selling rather than treating.
Eight things to settle before a prescription is written
- What symptom or health goal are we treating?
- Would local treatment be enough, or are we discussing systemic therapy?
- If I have a uterus, what endometrial protection is needed?
- How does my personal and family history change the risk discussion?
- Does route – oral, transdermal, or local – matter in my situation?
- What benefits should I reasonably notice, and over what time frame?
- What side effects or changes should prompt a call?
- When will we review whether this is still the right plan?
A decision can be thoughtful without being permanent
The goal is not to join a hormone-therapy camp. It is to make a decision that fits the symptom, the evidence, your preferences, and the health history in front of you, and then to put a review date on it. Treatment can be adjusted. Questions can change. The fact that menopause is a normal life stage does not mean symptoms have to be endured, and the fact that treatment can be helpful does not make it compulsory.
Sources reviewed
- ACOG – Hormone Therapy for Menopause
- ACOG – Can hormone therapy during menopause help me lose weight?
- Office on Women's Health – Menopause symptoms and relief
Claire Elise Wellness provides general education, not diagnosis or individualized medical care. If a symptom is severe, rapidly changing, or affecting your safety, use the level of care appropriate to the situation.
Two of the decisions above have notes of their own: hot flashes and night sweats, and vaginal dryness and urinary urgency. The Claire Elise Wellness hub holds the full index, method, and scope.